Microsoft Corporation (MSFT) — chart, structure and Closelook read

Pick a ticker to load its detail page.

About Microsoft Corporation

Microsoft Corporation (MSFT) trades on US exchanges. It is a constituent of Agentic Winners 40.

The print record

10 of 10 EPS beats and 10 of 10 revenue beats across the covered prints, with three-day reactions splitting 2 up · 3 flat · 5 down (as of the 2026-07-23 card). Twenty for twenty, and sold anyway. Microsoft has not missed a single estimate in ten prints — ten EPS beats, ten revenue beats, the only flawless operational record in this series — and the tape has paid it exactly twice: five selloffs against two rallies, capped by January 2026's −12.1% on a clean double beat. No card in the Print Record makes the season's point more expensively: the question is not whether the numbers are good. It is who keeps the money the numbers describe.

The full Microsoft Corporation print-record card →

closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: MSFT news on the tape · index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-08-28

Quick answers

What is Microsoft Corporation (MSFT)?

Microsoft Corporation trades as MSFT on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-08-28.

Is MSFT in a Closelook index?

Yes — Microsoft Corporation is a constituent of Agentic Winners 40, as of 2026-08-28.

What is Microsoft Corporation's earnings print record?

Across the 10 prints Closelook covers, Microsoft Corporation beat EPS estimates 10 times and revenue estimates 10 times; the three-day reactions split 2 up, 3 flat and 5 down (moves beyond ±3%), as of the 2026-07-23 card. The full print-record card carries the per-print history.

What does this page show?

A live price chart with SMA overlays and drawing tools for MSFT, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe